The synthesis and characterization of new bis(bipyridine)ruthenium(II) ferrocenyl ?-diketonate complexes, [(bpy)2Ru(Fc-acac)][PF6] (bpy=2,2?-bipyridine; Fc-acac=functionalized ligand) are reported. Alongside clinical platinum drugs, these bimetallic ruthenium-iron complexes have been screened for their cytotoxicity against MIA PaCa-2 (human pancreatic carcinoma), HCT116 p53+/+ colon carcinoma, ...